Please login to the form below

Not currently logged in

Sun Pharmaceutical Industries

This page shows the latest Sun Pharmaceutical Industries news and features for those working in and with pharma, biotech and healthcare.

Merck and Sun Pharma part company on branded generics

Merck and Sun Pharma part company on branded generics

Merck and Sun Pharma part company on branded generics. Will continue partnership on diabetes and inflammatory disorder projects. ... Merck &Co and India's Sun Pharmaceutical Industries have agreed to dissolve a joint venture set up in 2011 to develop and

Latest news

  • Sun Pharma recalls antidepressant in US Sun Pharma recalls antidepressant in US

    Sun Pharma recalls antidepressant in US. Withdraws more than 40, 000 bottles of venlafaxine hydrochloride. ... India-based Sun Pharmaceutical Industries is to recall more than 40, 000 bottles of an antidepressant after the drug was discovered to have

  • Pfizer sales dip as net income surges in Q2 Pfizer sales dip as net income surges in Q2

    from the spin-out of Zoetis and a litigation settlement with Teva and Sun Pharmaceutical Industries for patent infringement of Protonix (pantoprazole) fell 5 per cent.

  • MSD forms joint venture with Sun Pharma

    MSD (known as Merck in the US and Canada) has entered into a joint venture with India's Sun Pharmaceutical Industries to develop, manufacture and commercialise new combinations and formulations of ... The company has a proven track record in innovative

  • Thin on the ground

    Rheumatoid arthritis. Europe. Rivastigmine. Watson Pharmaceuticals. Dementia. US. Rivastigmine. Sun Pharmaceutical Industries. ... Lysteda (Ferring Pharmaceuticals). Cyclic heavy menstrual bleeding. US. Venlafaxine. Teva Pharmaceutical Industries.

  • Taro shareholders' meeting postponed

    Taro shareholders' meeting postponed. US-headquartered Taro Pharmaceutical Industries has postponed its proposed shareholder meeting on 25 September, which was to discuss the proposed merger with India's Sun Pharmaceutical Industries. ... India's largest

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • Pharma deals during April 2014 Pharma deals during April 2014

    1999 by the merger of RiboGene and Cypros Pharmaceutical), for $5.6bn representing a 27% premium. ... April also saw Sun Pharmaceutical Industries relieving Daiichi Sankyo (63.9% owner) of the troubled Ranbaxy Laboratories to create India's largest

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...